Life Science Analytics Market Growth by Applicatio, Type, Delivery, End User and Region
According to the new market research report Life Science Analytics Market
is expected to reach 42.0 billion by 2025 from USD 22.1 billion in
2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653
Growth
in this life science analytics software market is mainly driven by
technological advancements, big data in the life science industry,
growing adoption of analytics solutions in clinical trials, increasing
adoption of analytics for sales & marketing applications, need for
improved data standardization, increasing prevalence of chronic
diseases, growing pressure to curb healthcare spending, and the need for
improved patient outcomes. On the other hand, high implementation costs
are expected to restrain the growth of this market to a certain extent.
Based
on application, the life science analytics market is segmented into
research & development (clinical trials and preclinical trials),
sales & marketing, regulatory compliance, supply chain optimization,
and pharmacovigilance. The sales & marketing segment is expected to
grow at the highest CAGR during the forecast period.
Based on
type, the pharmaceutical life science analytics market is segmented into
descriptive analytics, predictive analytics, and prescriptive
analytics. The descriptive analytics segment accounted for the largest
share of the Life Science Analytics Market in 2019. The large share of
this segment is attributed to the significant usage of descriptive
analytics by stakeholders to gain a better understanding of the past
trends and events occurring in real-time.
Based on the delivery
mode, the Pharmaceutical Life Science Analytics Market is segmented into
the on-demand model and the on-premise model. The on-demand model
segment is expected to grow at the highest CAGR during the forecast
period, owing to advantages such as increasing demand for self-driven
analytics, lack of upfront capital investments for hardware, extreme
capacity flexibility, and pay-as-you-go pricing of this model.
In
2019, North America accounted for the largest market share, followed by
Europe. The large share of this market can primarily be attributed to
the strong economies in the US and Canada, which have allowed for
significant investments in technology in this region. Growth in the
North American market is supported by the growing adoption of IT in the
life science industry, rising pressure to reduce healthcare costs,
stringent regulations for the pharma-biotech and medical device
industries, and the greater product and service availability in this
region.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653
The
prominent players operating in the Life Science Analytics Market are
Oracle Corporation (US), Accenture (Ireland), SAS Institute Inc. (US),
IBM Corporation (US), Wipro (India), Cognizant (US), SCIO Health
Analytics (US), Allscripts Healthcare Solutions (US), Cerner Corporation
(US), IQVIA (US), Microsoft (US), Infosys Limited (US), MaxisIT (US),
Optum (US), and Cotiviti (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment